Continuous glucose monitoring in primary care: a news article summarizing a randomized trial exploring CGM use for adults with type 2 diabetes managed without insulin.
Key Takeaways
- CONNECT trial randomized 283 adults across 22 primary care practices
- Continuous glucose monitoring reduced A1C by 0.9% more than routine care
- Time in the 70 to 180 mg/dL target range increased by about five hours daily